Frequent promoter hypermethylation of the O6-Methylguanine-DNA Methyltransferase (MGMT) gene in testicular cancer.

Abstract:

:Testicular germ cell tumours are classified into two major histological subgroups, seminomas and nonseminomas. All tumours display several recurrent chromosomal aberrations, but few target genes have been identified. Previous studies have shown that genome-wide hypermethylation of CpG islands is significantly more prevalent in nonseminomas than in seminomas. We have studied two potential target genes in testicular cancer. A series of 70 tumours were analysed for methylation of CpG sites in the O(6)-methylguanine-DNA methyltransferase (MGMT) gene promoter, and in exon 1alpha of the cyclin-dependent kinase inhibitor 2A gene (CDKN2A). In addition, eight microsatellite markers within and flanking these genes at chromosome arms 10q and 9p, respectively, were analysed for allelic imbalances. Allele alterations were frequently seen at 9p loci (47 out of 70, 67%), but none of the tumours (none out of 55) showed methylation of CDKN2A. On the other hand, a high frequency of MGMT promoter methylation (32 out of 69, 46%) was found, as well as allelic imbalances at 10q markers (50 out of 70, 71%). A significantly higher methylation frequency was found in nonseminomas (24 out of 35, 69%) compared to seminomas (eight out of 33, 24%) (P=0.0003, Fisher's exact test). Immunohistochemical analysis of the MGMT protein in a subgroup (n=20) of the testicular tumours supported the hypothesis of gene silencing being the functional consequence of the promoter methylation. In summary, our data suggest that inactivation of MGMT contributes to development of nonseminomatous testicular cancer.

journal_name

Oncogene

journal_title

Oncogene

authors

Smith-Sørensen B,Lind GE,Skotheim RI,Fosså SD,Fodstad Ø,Stenwig AE,Jakobsen KS,Lothe RA

doi

10.1038/sj.onc.1205978

subject

Has Abstract

pub_date

2002-12-12 00:00:00

pages

8878-84

issue

57

eissn

0950-9232

issn

1476-5594

journal_volume

21

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • The erythropoietin-receptor pathway modulates survival of cancer cells.

    abstract::Anemia in cancer patients is associated with reduced quality of life and local failure after radiation treatment. However, the use of erythropoietin to correct cancer anemia and to improve radiation efficacy was disappointing. Erythropoietin-receptor signaling mainly acts via activation of STAT 5, but also crossactiva...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208140

    authors: Pajonk F,Weil A,Sommer A,Suwinski R,Henke M

    更新日期:2004-11-25 00:00:00

  • LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein.

    abstract::We previously reported cloning the rLot1 gene, and its human homolog (hLOT1), through analysis of differential gene expression in normal and malignant rat ovarian surface epithelial cells. Both human and rat ovarian carcinoma cell lines exhibited lost or decreased expression of this gene. Interestingly, the LOT1 gene ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203067

    authors: Abdollahi A,Bao R,Hamilton TC

    更新日期:1999-11-11 00:00:00

  • Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis.

    abstract::Colitis-associated colorectal cancers are an etiologically distinct subgroup of colon cancers that occur in individuals suffering from inflammatory bowel disease and arise as a consequence of persistent exposure of hyperproliferative epithelial stem cells to an inflammatory microenvironment. An intrinsic defect in the...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.545

    authors: Kosa P,Szabo R,Molinolo AA,Bugge TH

    更新日期:2012-08-09 00:00:00

  • Inhibition of endogenous reverse transcriptase antagonizes human tumor growth.

    abstract::Undifferentiated cells and embryos express high levels of endogenous non-telomerase reverse transcriptase (RT) of retroposon/retroviral origin. We previously found that RT inhibitors modulate cell growth and differentiation in several cell lines. We have now sought to establish whether high levels of RT activity are d...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208562

    authors: Sciamanna I,Landriscina M,Pittoggi C,Quirino M,Mearelli C,Beraldi R,Mattei E,Serafino A,Cassano A,Sinibaldi-Vallebona P,Garaci E,Barone C,Spadafora C

    更新日期:2005-06-02 00:00:00

  • Overexpression of wild-type p53 interferes with normal development in Xenopus laevis embryos.

    abstract::We have cloned and sequenced a Xenopus p53 homologue which differs by one amino acid deletion from a previously published Xenopus sequence (Soussi et al., 1987). Transcription analysis revealed that this gene is activated during early oogenesis and that zygotic transcription initiates after midblastula transition. Tra...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Hoever M,Clement JH,Wedlich D,Montenarh M,Knöchel W

    更新日期:1994-01-01 00:00:00

  • High frequency of p16INK4A gene alterations in hepatocellular carcinoma.

    abstract::The tumor suppressor gene p16 (CDKN2/MTS-1/INK4A) is an important component of the cell cycle and inactivation of the gene has been found in a variety of human cancers. In order to investigate the role of p16 gene in the tumorigenesis of hepatocellular carcinoma (HCC), 48 cases of HCC were analysed for p16 alterations...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202359

    authors: Liew CT,Li HM,Lo KW,Leow CK,Chan JY,Hin LY,Lau WY,Lai PB,Lim BK,Huang J,Leung WT,Wu S,Lee JC

    更新日期:1999-01-21 00:00:00

  • Lack of CD45 in FLT3-ITD mice results in a myeloproliferative phenotype, cortical porosity, and ectopic bone formation.

    abstract::The receptor tyrosine kinase FLT3 is expressed in myeloid and lymphoid progenitor cells. Activating mutations in FLT3 occur in 25-30% of acute myeloid leukaemia (AML) patients. Most common are internal tandem duplications of sequence (ITD) leading to constitutive FLT3-ITD kinase activity with an altered signalling qua...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0757-y

    authors: Kresinsky A,Schnöder TM,Jacobsen ID,Rauner M,Hofbauer LC,Ast V,König R,Hoffmann B,Svensson CM,Figge MT,Hilger I,Heidel FH,Böhmer FD,Müller JP

    更新日期:2019-06-01 00:00:00

  • Fusion of the EWS gene to CHN, a member of the steroid/thyroid receptor gene superfamily, in a human myxoid chondrosarcoma.

    abstract::The specific chromosomal translocation t(9;22)(q22-31;q11-12) has been observed in the myxoid variant of human chondrosarcoma. In agreement with this observation we report that the EWS gene located at chromosome band 22q12 becomes fused to CHN, a member of the steroid/thyroid receptor gene superfamily located at 9q22-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Clark J,Benjamin H,Gill S,Sidhar S,Goodwin G,Crew J,Gusterson BA,Shipley J,Cooper CS

    更新日期:1996-01-18 00:00:00

  • Drosophila Abelson kinase mediates cell invasion and proliferation through two distinct MAPK pathways.

    abstract::The Abelson (Abl) family of non-receptor tyrosine kinases has an important role in cell morphogenesis, motility, and proliferation. Although the function of Abl has been extensively studied in leukemia, its role in epithelial cell invasion remains obscure. Using the Drosophila wing epithelium as an in vivo model syste...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.155

    authors: Singh J,Aaronson SA,Mlodzik M

    更新日期:2010-07-15 00:00:00

  • Analysis of TEL proteins in human leukemias.

    abstract::Chromosomal translocations involving the human 12p13 band frequently affect the TEL gene, usually resulting in gene fusion between TEL and genes encoding proteins of various types. The most frequent 12p13 translocation is the t(12;21)(p13;q22), which recombines TEL with the AML1 gene on chromosome 21 and is frequently...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201817

    authors: Poirel H,Lacronique V,Mauchauffé M,Le Coniat M,Raffoux E,Daniel MT,Erickson P,Drabkin H,MacLeod RA,Drexler HG,Ghysdael J,Berger R,Bernard OA

    更新日期:1998-06-04 00:00:00

  • Ero1-L alpha plays a key role in a HIF-1-mediated pathway to improve disulfide bond formation and VEGF secretion under hypoxia: implication for cancer.

    abstract::Oxygen is the ultimate source of oxidizing power for disulfide bond formation, suggesting that under limiting oxygen proper protein folding might be compromised. We show that secretion of vascular endothelial growth factor (VEGF), a protein with multiple disulfide bonds, was indeed impeded under hypoxia and was partia...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208325

    authors: May D,Itin A,Gal O,Kalinski H,Feinstein E,Keshet E

    更新日期:2005-02-03 00:00:00

  • Hsp90-inhibitor geldanamycin abrogates G2 arrest in p53-negative leukemia cell lines through the depletion of Chk1.

    abstract::Checkpoint protein Chk1 has been identified as an Hsp90 client. Treatment with 100 nM geldanamycin (GM) for 24 h markedly reduced the Chk1 amount in Jurkat and ML-1 leukemia cell lines. Because Chk1 plays a central role in G2 checkpoint, we added GM to G2-arrested Jurkat and HL-60 cells pretreated with 50 nM doxorubic...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210978

    authors: Sugimoto K,Sasaki M,Isobe Y,Tsutsui M,Suto H,Ando J,Tamayose K,Ando M,Oshimi K

    更新日期:2008-05-15 00:00:00

  • Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK).

    abstract::To understand the mechanism of interferon (IFN)-mediated suppression of cell cycle progression, we have earlier shown that IFN-alpha enhances the expression of underphosphorylated retinoblastoma protein by inhibiting the cyclin-dependent kinase-2 (CDK-2) activity (Kumar and Atlas, Proc. Natl. Acad. Sci. 89, 6599-6603,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201529

    authors: Mandal M,Bandyopadhyay D,Goepfert TM,Kumar R

    更新日期:1998-01-15 00:00:00

  • hpttg, a human homologue of rat pttg, is overexpressed in hematopoietic neoplasms. Evidence for a transcriptional activation function of hPTTG.

    abstract::We have isolated a human cDNA clone encoding a novel protein of 22 kDa that is a human counterpart of the rat oncoprotein PTTG. We show that the corresponding gene (hpttg) is overexpressed in Jurkat cells (a human T lymphoma cell line) and in samples from patients with different kinds of hematopoietic malignancies. An...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202140

    authors: Domínguez A,Ramos-Morales F,Romero F,Rios RM,Dreyfus F,Tortolero M,Pintor-Toro JA

    更新日期:1998-10-29 00:00:00

  • High levels of the c-myc protein in cell lines of Bloom's syndrome origin.

    abstract::Lymphoblastoid cell lines derived from cancer prone Bloom's Syndrome patients differ from cell lines representative of several other disorders by exhibiting a constitutive elevation in the level of the c-myc protein. This may be a contributing factor in the strong predisposition to malignancy observed in Bloom's syndr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Sullivan NF,Willis AE,Moore JP,Lindahl T

    更新日期:1989-12-01 00:00:00

  • Activation of oncogenes in human oral cancer cells: a novel codon 13 mutation of c-H-ras-1 and concurrent amplifications of c-erbB-1 and c-myc.

    abstract::By NIH3T3 transfection assay in conjunction with in vitro transient neomycin selection, activated c-H-ras-1 oncogenes were detected in two squamous cell carcinoma cell lines, ZA and HOC-313, newly established from human oral cancer patients. ZA had a point mutational activation at the 13th codon, this activation of c-...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Tadokoro K,Ueda M,Ohshima T,Fujita K,Rikimaru K,Takahashi N,Enomoto S,Tsuchida N

    更新日期:1989-04-01 00:00:00

  • Regulation of fibronectin matrix assembly by activated Ras in transformed cells.

    abstract::Fibronectin extracellular matrix plays a critical role in the microenvironment of cells. Loss of this matrix frequently accompanies oncogenic transformation, allowing changes in cell growth, morphology, and tissue organization. The HT1080 human fibrosarcoma cell line is deficient in formation of fibronectin matrix fib...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203626

    authors: Brenner KA,Corbett SA,Schwarzbauer JE

    更新日期:2000-06-29 00:00:00

  • How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions?

    abstract::Cancer cells enhance their glycolysis, producing lactate, even in the presence of oxygen. Glycolysis is a series of ten metabolic reactions catalysed by enzymes whose expression is most often increased in tumour cells. HKII and phosphoglucose isomerase (PGI) have mainly an antiapoptotic effect; PGI and glyceraldehyde-...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2014.320

    authors: Lincet H,Icard P

    更新日期:2015-07-01 00:00:00

  • Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations.

    abstract::An oncogenic mutation (G49A:E17K) in the AKT1 gene has been described recently in human breast, colon, and ovarian cancers. The low frequency of this mutation and perhaps other selective pressures have prevented the isolation of human cancer cell lines that harbor this mutation thereby limiting functional analysis. He...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.516

    authors: Lauring J,Cosgrove DP,Fontana S,Gustin JP,Konishi H,Abukhdeir AM,Garay JP,Mohseni M,Wang GM,Higgins MJ,Gorkin D,Reis M,Vogelstein B,Polyak K,Cowherd M,Buckhaults PJ,Park BH

    更新日期:2010-04-22 00:00:00

  • Modulation of cellular apoptotic potential: contributions to oncogenesis.

    abstract::The importance of apoptosis as a natural means to eliminate unwanted or damaged cells has been realized over the past decade. Many components required to exercise programmed cell death have been identified and shown to pre-exist in most, if not all, cells. Such ubiquity requires that apoptosis be tightly controlled an...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1203126

    authors: Stambolic V,Mak TW,Woodgett JR

    更新日期:1999-11-01 00:00:00

  • Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.

    abstract::The human T-cell leukemia virus type 1 (HTLV-1) was the first retrovirus discovered to be causative of a human cancer, adult T-cell leukemia. The transforming entity of HTLV-1 has been attributed to the virally-encoded oncoprotein, Tax. Unlike the v-onc proteins encoded by other oncogenic animal retroviruses that tran...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2010.537

    authors: Matsuoka M,Jeang KT

    更新日期:2011-03-24 00:00:00

  • Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition.

    abstract::Epithelial-to-mesenchymal transition (EMT), marked by the dissolution of cell-cell junctions, loss of cell polarity and increased cell motility, is one of the essential steps for prostate cancer metastasis. However, the underlying mechanism has not been fully explored. We report in this study that Shp2 is upregulated ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.184

    authors: Zhang K,Zhao H,Ji Z,Zhang C,Zhou P,Wang L,Chen Q,Wang J,Zhang P,Chen Z,Zhu HH,Gao WQ

    更新日期:2016-03-10 00:00:00

  • DNA damage checkpoint control in cells exposed to ionizing radiation.

    abstract::Damage induced in the DNA after exposure of cells to ionizing radiation activates checkpoint pathways that inhibit progression of cells through the G1 and G2 phases and induce a transient delay in the progression through S phase. Checkpoints together with repair and apoptosis are integrated in a circuitry that determi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206682

    authors: Iliakis G,Wang Y,Guan J,Wang H

    更新日期:2003-09-01 00:00:00

  • Physical interaction of estrogen receptor with MnSOD: implication in mitochondrial O2.- upregulation and mTORC2 potentiation in estrogen-responsive breast cancer cells.

    abstract::Augmented reactive oxygen species levels consequential to functional alteration of key mitochondrial attributes contribute to carcinogenesis, either directly via oxidative DNA damage infliction or indirectly via activation of oncogenic signaling cascades. We previously reported activation of a key oncogenic signaling ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.346

    authors: Lone MU,Baghel KS,Kanchan RK,Shrivastava R,Malik SA,Tewari BN,Tripathi C,Negi MP,Garg VK,Sharma M,Bhatt ML,Bhadauria S

    更新日期:2017-03-30 00:00:00

  • Overexpression confers an oncogenic potential upon the eph gene.

    abstract::The eph gene encodes a putative receptor tyrosine kinase for an as yet unknown ligand. Some human cancer cells have been found to overexpress eph mRNAs without gene amplification. We show here that NIH3T3 cells acquire tumorigenic ability in nude mice and make colonies in soft agar with a viral LTR (Long Terminal Repe...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Maru Y,Hirai H,Takaku F

    更新日期:1990-03-01 00:00:00

  • Iron regulatory protein 2 is a suppressor of mutant p53 in tumorigenesis.

    abstract::p53 is known to play a role in iron homeostasis and is required for FDXR-mediated iron metabolism via iron regulatory protein 2 (IRP2). Interestingly, p53 is frequently mutated in tumors wherein iron is often accumulated, suggesting that mutant p53 may exert its gain of function by altering iron metabolism. In this st...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0876-5

    authors: Zhang Y,Feng X,Zhang J,Chen M,Huang E,Chen X

    更新日期:2019-08-01 00:00:00

  • Actin cytoskeleton polymerization in Dbl-transformed NIH3T3 fibroblasts is dependent on cell adhesion to specific extracellular matrix proteins.

    abstract::The Dbl oncogene is the putative exchange factor for two small GTP-binding proteins, RhoA and CDC42 which are involved in the polymerization of actin to produce stress fibers and filopodia, respectively. We report here that Dbl oncogene-transformed NIH3T3 cells show actin stress fibers only when cells are plated on fi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201027

    authors: Defilippi P,Olivo C,Tarone G,Mancini P,Torrisi MR,Eva A

    更新日期:1997-04-24 00:00:00

  • The oncogene PDGF-B provides a key switch from cell death to survival induced by TNF.

    abstract::Tumor necrosis factor (TNF) induces both cell death and survival signals. NF-kappaB, a transcription factor activated by TNF, is critical for controlling survival signals through trans-activation of downstream target genes. However, few NF-kappaB target survival genes have been identified with direct roles in oncogene...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208516

    authors: Au PY,Martin N,Chau H,Moemeni B,Chia M,Liu FF,Minden M,Yeh WC

    更新日期:2005-04-28 00:00:00

  • Degradation of B-Myb by ubiquitin-mediated proteolysis: involvement of the Cdc34-SCF(p45Skp2) pathway.

    abstract::B-Myb, a highly conserved member of the Myb oncoprotein family, is a 110 kDa sequence-specific DNA binding protein expressed in virtually all proliferating cells. B-myb expression reaches its maximum at the G1/S phase boundary and during the S phase of the cell cycle. We have previously shown that B-Myb activity is ce...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203618

    authors: Charrasse S,Carena I,Brondani V,Klempnauer KH,Ferrari S

    更新日期:2000-06-15 00:00:00

  • Synergy of Nf2 and p53 mutations in development of malignant tumours of neural crest origin.

    abstract::Previously, we have mimicked human neurofibromatosis type 2 (NF2) in conditional Nf2 mutant (P0Cre;Nf2flox2/flox2) mice. Schwannomas, characteristic for NF2, were found at low frequency in older mice. Here, we report that these mice, upon additional hemizygosity for p53, rapidly develop multiple tumours showing featur...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207858

    authors: Robanus-Maandag E,Giovannini M,van der Valk M,Niwa-Kawakita M,Abramowski V,Antonescu C,Thomas G,Berns A

    更新日期:2004-08-26 00:00:00